2017 Data Sources

In this report, we have selected 18 out of the 232 SDG indicators. Below are the sources for the chart data. Where the Institute for Health Metrics and Evaluation has a measurement definition that needs further explanation, we have included additional details below. The 2030 global targets included on the charts illustrate the progress the world is aiming to achieve. Some SDG indicators have a quantifiable global target (e.g., maternal mortality), some have a quantifiable country target (e.g., child and neonatal mortality), which we have extrapolated to a global level, and for others we have used the WHO proposed 2030 targets (e.g., for HIV, malaria, and TB).

Read the 2017 Report

Poverty

Homi Kharas, the Brookings Institution, personal correspondence, July 2017.

Financial Services for the Poor

Global data for the “Current projection” scenario is based on the following sources:

2005 and 2008: International Monetary Fund, Financial Access Survey. http://data.imf.org/FAS.

2011 and 2014: World Bank, Global Financial Inclusion (Global Findex) Database. http://datatopics.worldbank.org/financialinclusion/.

2015 and beyond: Manyika, J., Lund, S., Singer, M., White, 0., and Berry, C., “Digital finance for all: Powering inclusive growth in emerging economies.” McKinsey Global Institute, September, 2016. http://www.mckinsey.com/global-themes/employment-and-growth/how-digital-finance-could-boost-growth-in-emerging-economies.

Field, E., Pande, R., Rigol, N., Schaner, S., and Moore, C. T., “On Her Account: Can Strenghtening Women’s Financial Control Boost Female Labor Supply?” November 15, 2016. http://scholar.harvard.edu/files/rpande/files/on_her_account.can_strengthening_womens_financial_control_boost_female_labor_supply.pdf.

Jack, W., and Suri, T., “The long-run poverty and gender impacts of mobile money.” Science, December 9, 2016. http://science.sciencemag.org/content/354/6317/1288.

All Other Charts

Estimates are from the Institute for Health Metrics and Evaluation (IHME) at the University of Washington. Methodologies for scenarios: “If we progress” scenarios are derived from setting the rates of change to the 85th percentile of historical median annual rates of change across countries. “If we regress” scenarios are derived from setting rates of change to the 15th percentile of historical median annual rates of change across countries. Current projections are based on past trends.

For further information on IHME data, please visit http://healthdata.org/globalgoals,

and read the fortcominng article by Global Burden of Disease (GBD) 2016 SDG collaborators in the September 2017 volume of Lancet, “Measuring progress and projecting attainment based on past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Gloal Burden of Disease Study 2016.” The Lancet. 2017 Sept.

Further details on IHME’s definitionns for the following indicators:

Neglected Tropical Diseases

IHME measures the sum of the prevalence of 15 NTDs per 100,000, currently measured in the Global Burden of Disease study: Human African trypanosomiasis, Chagas disease, cystic echinococcosis, cysticercosis, dengue, food-borne trematodiases, Guinea worm, intestinal nematode infections, leishmaniasis, leprosy, lymphatic filariasis, onchocerciasis, rabies, schistosomiasis, and trachoma.

Universal Health Coverage

Defined by a UHC index of the coverage of nine tracer interventions and risk-standardized death rates from 32 causes amenable to personal healthcare. Tracer interventions include: vaccination coverage (coverage of three doses of DPT, measles vaccine, and three doses of the oral polio vaccinne or inactivated polio vaccine); met need for modern contraception; ANC coverage; SBA coverage; in-facility delivery rates; and coverage of antiretroviral therapy among respiratory infections, upper respiratory infections, diphtheria, whooping cough, tetanus, measles, maternal disorders, neonatal disorders, colon and rectal cancer, non-melanoma cancer, breast cancer, cervical cancer, uterine cancer, testicular cancer, Hodgkin’s lymphona, leukemia, rheumatic heart disease, ischaemic heart disease, cerebrovascular disease, hypertensive heart disease, congenital heart anomalies, and adverse effects of medical treatment.

IHME then scaled 41 inputs on a scale of 0 to 100, with 0 reflecting the worst levels observed between 1990 to 2016 and 100 reflecting the best observed. They took the arithmetic mean of these 41 scaled indicators to capture a wide range of essential health services pertaining to reproductive, maternal, newborn, and child health; infectious diseases; noncommunicable disesases; and service capacity access.

Vaccines

IHME’s measurement included the following vaccines: DPT (three doses), measles (one dose), BCG, polio vaccine (three doses), hepatitis B (three doses), Haemophilus influenzae type b (Hib, three doses), pneumococcal conjugate vaccine (PCV, three doses), and rotavirus vaccine (two or three doses). IHME used the geometric mean of coverage of these eight vaccines, based on their inclusion in a country’s national vaccine schedule.

Sanitation

IHME measured households with piped sanitation (with a sewer connection); households with improved sanitation without a sewer connection (pit latrine, ventilated improved latrine, pit latrine with slab, composting toilet); and households without improved sanitation (flush toilet that is not piped to sewer or septic tank, pit latrine without a slab or open pit, bucket, hanging toilet or hanging latrine, shared facilities, no facilities), as defined by the Joint Monitoring Program.